Neuland Laboratories (NEULANDLAB) Share Price Falls 2.04% as Large Cap Pharma Stock Trades Lower

Neuland Laboratories Share Price was at Rs 20,155, down 2.04% from the previous close, and the company’s market capitalisation stood at Rs 26,788.62 crore. The move kept Neuland Laboratories Share Price in focus as a Large Cap healthcare name, with the day’s trade showing a lower open, a brief move up to Rs 20,695, and a low of Rs 19,952.05. According to latest Univest figures, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Neuland Laboratories Share Price Today, the key question is not only the fall itself, but how the valuation, profitability ratios and peer context frame Neuland Laboratories Share News. Univest data shows a meaningful gap between the stock’s market valuation and the broader industry benchmark, which is relevant for anyone reviewing Neuland Laboratories Stock News or Neuland Laboratories Stock Analysis.

Neuland Laboratories (NEULANDLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 20,155
Previous Close	Rs 20,574.2
Today's Move	-Rs 419.20 (-2.04%)
Open	Rs 20,694.9
High	Rs 20,695
Low	Rs 19,952.05
Market Capitalisation	Rs 26,788.62 crore
Market Cap Category	Large Cap

Neuland Laboratories Share Price opened at Rs 20,694.90, touched a high of Rs 20,695 and a low of Rs 19,952.05, and last traded at Rs 20,155 as of 13 October 2026 at 9:23:26 AM IST. That puts Neuland Laboratories Share Price below the previous close of Rs 20,574.20 by Rs 419.20, matching a decline of 2.04%. The stock’s market capitalisation of Rs 26,788.62 crore places it firmly in the Large Cap category. For Neuland Laboratories Share Price Today, the range shows a relatively wide move between the morning high and low, while the current price remains closer to the lower end of that band. In Neuland Laboratories Stock News terms, the trading pattern is straightforward: price fell, the gap to the prior close is clear, and the move is visible without needing extra interpretation. The next layer is whether the company’s fundamental profile justifies ongoing attention, which is where Neuland Laboratories Share Price analysis becomes more useful.

Neuland Laboratories (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 26,788.62 crore
P/E Ratio	53.03x
P/B Ratio	13.06x
ROE	21.43%
ROCE	27.5%
EPS	Rs 387.98
Book Value Per Share	Rs 1,575.41
Dividend Yield	0.17%

Neuland Laboratories (NEULANDLAB) fundamental metrics show P/E 53.03x, P/B 13.06x, ROE 21.43%, ROCE 27.5%. Read together, these ratios describe the company's position rather than a recommendation.

Neuland Laboratories has a market capitalisation of Rs 26,788.62 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 53.03x, P/B at 13.06x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.43% and ROCE of 27.5%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 387.98, book value per share of Rs 1,575.41, dividend yield of 0.17%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.63x, median ROE of 11.61%, median ROCE of 13.46%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	53.03x
Benchmark Median P/E	31.63x
Benchmark Average P/E	47.13x
Benchmark P/E Range	3.21x to 676.52x
Company P/B Ratio	13.06x
Benchmark Median P/B	2.86x
Benchmark Average P/B	4.25x
Company ROE	21.43%
Benchmark Median ROE	11.61%
Benchmark Average ROE	10.59%
Company ROCE	27.5%
Benchmark Median ROCE	13.46%
Benchmark Average ROCE	13.35%
Company Market Capitalisation	Rs 26,788.62 crore
Benchmark Median Market Cap	Rs 814.52 crore
Benchmark Average Market Cap	Rs 13,724.94 crore

Neuland Laboratories (NEULANDLAB) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

Neuland Laboratories (NEULANDLAB) has a P/E ratio of 53.03x, which is above the benchmark median of 31.63x, a difference of +67.66%. The P/E comparison frames valuation; it is not a signal to buy or sell.

Neuland Laboratories (NEULANDLAB) has a ROE of 21.43%, which is above the benchmark median of 11.61%, a difference of +84.58%. Neuland Laboratories (NEULANDLAB) has a ROCE of 27.5%, which is above the benchmark median of 13.46%, a difference of +104.31%.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,21,539.16	34.89	4.88	14.85	19.11
Divi's Laboratories	DIVISLAB	2,47,576	85.12	14.1	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,77,251.42	81.6	19.83	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,11,231.65	25.18	4.21	19.69	21.39
Laurus Labs	LAURUSLABS	1,09,796.85	102.34	19.84	18.31	18.2

Neuland Laboratories (NEULANDLAB) has a P/E ratio of 53.03x compared with the displayed peer median of 81.6x. Peer multiples give relative context only, not a buy or sell view. Its ROE of 21.43% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 27.5% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Neuland Laboratories (NEULANDLAB) has a market capitalisation of Rs 26,788.62 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Neuland Laboratories

• Neuland Laboratories Share Price is trading lower by 2.04%, keeping the intraday move in clear focus.
• Neuland Laboratories Share Price remains supported by ROE of 21.43% and ROCE of 27.5%.
• Neuland Laboratories Share Price carries a P/E of 53.03 and a P/B of 13.06, both above the industry benchmark.
• Neuland Laboratories Share Price sits in the Large Cap category with market capitalisation of Rs 26,788.62 crore.
• Neuland Laboratories Share News stays relevant because the stock trades at a premium versus many healthcare peers.

About Neuland Laboratories

Neuland Laboratories operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. Neuland Laboratories Share Price reflects a company positioned in the listed pharma space where valuation and return ratios often matter as much as headline price movement. The business context relevant here is the company’s place among large listed healthcare peers, with a market capitalisation that places it above the industry median and above the industry average. Neuland Laboratories Stock News therefore tends to be interpreted through earnings quality, return on capital and peer valuation, rather than through a simple price move alone. For Neuland Laboratories Share Price Today, that positioning is central to how the market reads each intraday decline.

Track Neuland Laboratories Share Price on Univest

Use Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

On Univest, readers can track Neuland Laboratories Share Price alongside key fundamental ratios, market capitalisation, 52-week levels and market insights in one place. Univest also helps place Neuland Laboratories Share Price Today in context with sector benchmarks, peer comparison and company-level valuation data. For Neuland Laboratories Stock News followers, that makes it easier to review Neuland Laboratories Share Price News, Neuland Laboratories Latest News and Neuland Laboratories Share Price Update without losing the larger financial picture.

Frequently Asked Questions

Why is Neuland Laboratories Share Price falling today?

Ans. Neuland Laboratories Share Price fell 2.04% to Rs 20,155 in early trade. Univest data confirms the move itself, though no company-specific trigger has been identified. The move is therefore best read through price action and valuation context.

What is Neuland Laboratories Share Price today?

Ans. Neuland Laboratories Share Price was Rs 20,155 as of 13 October 2026 at 9:23:26 AM IST. It traded below the previous close of Rs 20,574.20 and remained within the day’s range of Rs 19,952.05 to Rs 20,695.

How much did Neuland Laboratories Share Price decline?

Ans. Neuland Laboratories Share Price declined by Rs 419.20, or 2.04%, versus the previous close. The move started from an open of Rs 20,694.90 and remained under pressure relative to the day’s high of Rs 20,695.

What is Neuland Laboratories market capitalisation?

Ans. Neuland Laboratories Share Price is backed by a market capitalisation of Rs 26,788.62 crore. That places the company in the Large Cap category and above the same-industry median market capitalisation of Rs 814.52 crore.

How does Neuland Laboratories look on valuation?

Ans. Neuland Laboratories Share Price trades at a P/E of 53.03 and a P/B of 13.06. Both multiples are above the industry benchmark median and average, so the stock carries a richer valuation than many peers in Healthcare.

What do ROE and ROCE say about Neuland Laboratories?

Ans. Neuland Laboratories Share Price is supported by ROE of 21.43% and ROCE of 27.5%. These figures sit above the benchmark median and average, indicating strong return generation relative to the listed peer set.

What does EPS mean for Neuland Laboratories Share Price?

Ans. Neuland Laboratories Share Price has an EPS of Rs 387.98. EPS shows earnings attributable to each share, and this figure helps investors compare profitability with valuation ratios such as P/E and P/B.

What is the book value of Neuland Laboratories?

Ans. Neuland Laboratories Share Price has a book value of Rs 1,575.41 per share. Book value per share shows the accounting net worth behind each share, and it provides another reference point alongside the current market price.

How does Neuland Laboratories compare with healthcare peers?

Ans. Neuland Laboratories Share Price has a market cap below Sun Pharmaceutical and Divi’s Laboratories but above Zydus Lifesciences, Cipla and Dr. Reddy’s. Its P/E and P/B are also richer than most peers, while ROE and ROCE remain strong.